Lyophilised static human immunoglobulin (pH4)

【Ingredients】
       1. Human immunoglobulin, derived from healthy human plasma.
       2. Main excipients: maltose, 90-110g/L.
       3. Molecular Weight: 150,000

【Properties】

It should be a white or off-white loose body with no signs of melting. After reconstitution, it becomes a colorless or light yellow clear liquid with slight opalescence, and there should be no foreign matter, floc and precipitation.

【Indications】

1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency disease, immunoglobulin G subtype deficiency disease, etc.;
2. Secondary immunoglobulin deficiency diseases, such as severe infection, neonatal sepsis, etc.;
3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.

【Specification】
       IgG content 5%, 1.25g/bottle; IgG content 5%, 2.5g/bottle

【Dosage】

Usage: Strict aseptic operation is adopted for the freeze-dried preparation, and the matching sterile water for injection is added according to the prescribed amount, and gently swirled (avoiding a large amount of foam) to completely dissolve. When in use, use an infusion set with a filter for intravenous infusion. Infusion rate: The first time you use this product, start slowly, 1.0 ml/min (10-20 drops/min) for adults; if there is no adverse reaction after 15 minutes, you can gradually increase the rate, and the fastest infusion rate should not exceed 3.0 ml/min. minutes (about 60 drops/minute). Children's instillation speed is slowed down as appropriate.

【Contraindication】
       1. People who are allergic to human immunoglobulin or have a history of other severe allergies.
       2. Selective IgA deficient individuals with IgA antibodies.

【Precautions】

1. This product is exclusively for intravenous infusion.
2. This product should be infused alone and not mixed with other drugs.
3. After the product is dissolved, it should be a clear liquid. If there is turbidity, precipitation, foreign matter or bottle cracks, or expiration date, it should not be used.
4. After the product dissolves, it should be infused in one time, and it should not be divided into several times or given to the second person for infusion.
5. Patients with severe acid-base metabolism disorders should use it with caution.
6. If chills or fever occur during the infusion, the infusion speed should be suspended or slowed down.